Pathogenic Drug Resistant Fungi: A Review of Mitigation Strategies

Area of Science:

• Medical Mycology
• Infectious Diseases
• Drug Resistance

Background:

• Fungal pathogens cause significant global morbidity and mortality, disproportionately affecting immunocompromised individuals.
• Increasing antifungal drug resistance poses serious challenges for treating cutaneous, invasive, and bloodstream fungal infections.
• The World Health Organization's 2022 priority list highlights the critical need for solutions to the fungal resistance crisis.

Purpose of the Study:

• To review the challenges and implications of antifungal drug resistance.
• To discuss the effectiveness of current disease mitigation strategies.
• To explore cellular and molecular mechanisms underlying fungal resistance.

Main Methods:

• Literature review of antifungal drug resistance.
• Analysis of established decontamination and disease mitigation approaches.
• Discussion of cellular and molecular mechanisms of fungal resistance.

Main Results:

• Established decontamination methods are effective for medical devices but challenged by fungal biofilms.
• Antifungal resistance necessitates novel approaches for medical device design and food safety.
• Understanding resistance mechanisms is crucial for developing effective solutions.

Conclusions:

• Addressing antifungal drug resistance requires a multi-faceted approach, including improved medical device design and food safety protocols.
• Further research into the mechanisms of fungal resistance is essential for developing new treatments.
• Proactive strategies are needed to mitigate the impact of fungal pathogens and mycotoxins.